جستجوی استاد راهنمای دانشگاهی

Zaw Myo TUNمشاهده پروفایل

پژوهشگر ارشد

• Epidemiology
• Global Health
• Tuberculosis Vaccines
• +۳ مورد دیگر

Zaw Myo TUN is a Research Fellow (Adjunct) at the Saw Swee Hock School of Public Health, National University of Singapore, and serves as Senior Manager (Research and Evaluation) at IRD Global Singapore. His academic career includes roles such as Postdoctoral Fellow (2022) and Research Associate (2013–2021) at the same school. He holds a PhD from NUS (2016–2021), an MSc in Epidemiology from the London School of Hygiene & Tropical Medicine (2011–2012), and an MBBS from the University of Medicine, Mandalay, Myanmar (2003–2008). His research focuses on epidemiology, global health, tuberculosis vaccines, and public health policy. Key interests include maternal vaccination coverage in low-resource settings, hospital-acquired infections (e.g., MRSA), antibiotic resistance, and the ethical implications of pandemic control measures. He has contributed to studies on SARS-CoV-2 transmission dynamics, road traffic injury patterns in Bhutan, and malaria drug policy compliance in India. His publications analyze public perceptions of health policies, such as during the COVID-19 pandemic, and explore factors influencing healthcare behaviors in diverse populations. His work bridges clinical data (e.g., electronic medical records) and population-level health surveillance to inform evidence-based interventions. While no awards are explicitly mentioned, his research has addressed critical global health challenges like tuberculosis control in Myanmar and antimicrobial stewardship in Singapore primary care settings. Zaw Myo TUN’s career emphasizes translational research, linking academic findings to real-world health system improvements. His roles span academia and non-profit sectors, reflecting a commitment to addressing public health disparities through collaborative, policy-driven solutions.

Yu Heمشاهده پروفایل

استادیار

• Condensed Matter Physics
• Quantum Materials
• Superconductivity
• +۳ مورد دیگر

Yu He is an Assistant Professor of Applied Physics and Physics at Yale University, affiliated with the Department of Physics. His research focuses on condensed matter physics and experimental techniques such as angle-resolved photoemission spectroscopy (ARPES) and x-ray scattering to study correlated electronic systems and quantum materials. Prior to Yale, he completed a Miller Research Fellowship at UC Berkeley (2019) after earning his Ph.D. in Applied Physics from Stanford University. Key research areas include metal-to-insulator transitions, superconductivity, 2D magnetism, and solid-state quantum simulation. He has contributed to advancements in material characterization techniques, including high-resolution ARPES using tabletop lasers. His work integrates crystal synthesis, electric transport measurements, and surface decoration to explore material properties. Education: B.S. in Physics from University of Science and Technology of China (USTC); M.S. in Electrical Engineering and Ph.D. in Applied Physics from Stanford University. Research Interests: Experimental condensed matter physics, quantum materials, superconductivity, and light-matter interaction studies. His current projects aim to dissect microscopic degrees of freedom (electronic, lattice, spin) in novel materials using cutting-edge spectroscopic methods. The lab employs complementary techniques like electric transport measurements and crystal growth to characterize material properties comprehensively. Awards: Miller Research Fellow, UC Berkeley (2019) Advising & Grants: No student advisees listed. Research supported by Yale University and prior fellowships. Labs & Teams: Leads a research group at Yale focused on experimental condensed matter physics, collaborating on projects involving advanced material characterization and quantum material discovery.

Sharon Peacockمشاهده پروفایل

استاد

• Antimicrobial Resistance
• Infectious Disease Epidemiology
• Microbial Genomics
• +۳ مورد دیگر

Professor Sharon Peacock is a leading academic in medical microbiology and public health at the University of Cambridge. She holds the position of Executive Director & Chair of the COVID-19 Genomics UK Consortium (COG-UK) since 2020. Previously, she served as Professor of Clinical Microbiology at the London School of Hygiene & Tropical Medicine and University College London (2015-2019), and at the University of Cambridge Department of Medicine (2009-2015). Her research focuses on bacterial pathogens, antimicrobial resistance, and genomic surveillance of infectious diseases. Education and professional roles include non-executive directorships at Cambridge University Hospitals NHS Foundation Trust and Public Health England (seconded roles). She has been recognized with significant honors including Commander of the British Empire (CBE), MRC Millennium Medal, and Unilever Colworth Prize. Her work bridges laboratory research and public health policy, particularly in genomic epidemiology of pathogens like SARS-CoV-2 and MRSA. Key contributions include defining transmission patterns of nosocomial pathogens through genomic studies, developing strategies for antimicrobial resistance, and leading international responses to infectious disease outbreaks. Her research integrates clinical microbiology with advanced genomic technologies to inform global health strategies.

Jodi Lindsayمشاهده پروفایل

استاد

• Microbial Pathogenesis
• Antimicrobial Resistance
• Bacterial Evolution
• +۵ مورد دیگر

Professor Jodi Lindsay is a Professor of Microbial Pathogenesis at City St George's, University of London and serves as the Director of Cross Cutting Research Themes at the Infection and Immunity Research Institute. She is also Deputy to the Deputy Vice Chancellor (Research & Enterprise) and Academic Lead for REF2021. Dr. Lindsay earned her PhD from the University of Western Australia, followed by post-doctoral positions at New York University Medical Center and the University of Sheffield. She joined St George's in 1998, receiving tenure in 2005 and achieving full professorship in 2012. Her research focuses on: Evolution of bacterial populations and horizontal gene transfer Antimicrobial resistance (AMR) mechanisms in pathogens Staphylococcus aureus and MRSA epidemiology and evolution Bacteriophage transduction and restriction modification systems Genomic analysis of bacterial pathogenicity She leads a research team investigating AMR gene acquisition and stability through approaches including experimental evolution, mathematical modeling, and whole-genome sequencing. Key discoveries include Staphylococcus aureus pathogenicity islands (SaPI), lineage-specific restriction-modification systems, and AMR transmission dynamics. Current research funding includes support from MRC and JPI-AMR, with previous major grants from Wellcome Trust, EU FP7, BBSRC, and DEFRA. Her research team includes Jake Wildfire, Alastair Clements, Max Wallat, and Amelia Williams-Walker. She collaborates internationally with institutions including London School of Hygiene & Tropical Medicine, Imperial College London, Royal Veterinary College, and Erasmus Medical Centre. Dr. Lindsay teaches and supervises students in MRes Biomedical Science, BSc programs, and PhD candidates including MRC-LID students.

Byeonghwa Jeonمشاهده پروفایل

دانشیار

• Antibiotic Resistance
• Antimicrobial Alternatives
• Bacteriophages
• +۳ مورد دیگر

Dr. Byeonghwa Jeon is an Associate Professor in the Division of Environmental Health Sciences at the University of Minnesota. His research focuses on antibiotic resistance mechanisms, stress tolerance in foodborne pathogens, and development of antimicrobial alternatives such as bacteriophages and antioxidant-based therapies. Education: PhD in Veterinary Medical Sciences, University of Tokyo, Japan MSc in Food Science and Biotechnology, Lund University, Sweden BSc in Food Science and Technology, Seoul National University, Korea Postdoctorate in Veterinary Microbiology and Preventive Medicine, Iowa State University Dr. Jeon's research employs molecular biology, genomics, and microbial ecology to study Campylobacter jejuni, a leading enteric pathogen, with emphasis on stress responses, biofilm formation, and antibiotic resistance. His work aims to develop interventions to disrupt bacterial survival pathways and reduce public health impacts. Recent publications highlight his exploration of antioxidant-mediated antimicrobial synergy, cold tolerance mechanisms, and phage-based control of multidrug-resistant bacteria. Key collaborations include researchers from South Korea, Canada, and the U.S. Areas of investigation include: Stress tolerance in foodborne pathogens Molecular mechanisms of antibiotic resistance Bacteriophage applications for STEC and Salmonella Oxidative stress and biofilm regulation Wall teichoic acid roles in Listeria Adjuvant strategies for bacitracin against MRSA

Mark Smeltzerمشاهده پروفایل

استاد

• Bacterial Pathogenesis
• Antimicrobial Resistance
• Infectious Disease
• +۴ مورد دیگر

Mark Smeltzer is a Professor in the Department of Microbiology and Immunology and Department of Orthopaedics at the University of Arkansas for Medical Sciences (UAMS). He specializes in the molecular pathogenesis of Staphylococcus aureus infections, particularly focusing on its role in orthopaedic infections, biofilm formation, and antibiotic resistance mechanisms. His work integrates molecular biology, proteomics, and nanotechnology to develop novel therapeutic strategies. Dr. Smeltzer earned his Ph.D. from Kansas State University and completed postdoctoral training under Dr. John J. Iandolo. His research is supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID), the Congressionally-Directed Medical Research Program, and the Texas Hip and Knee Foundation. Key collaborations include projects with Dr. Jingyi Chen (nanotherapeutics) and Dr. Alexandru Biris (bone regeneration scaffolds). Research Interests: Mechanisms of S. aureus biofilm formation and antibiotic resistance Role of the sarA regulatory gene in virulence and infection Development of nanoparticle-based therapies for biofilm-associated infections Orthopaedic device-related infections and bone regeneration Key Findings: Identified sarA mutations limiting biofilm formation and enhancing antibiotic susceptibility Developed gold nanocage-based systems for targeted antibiotic delivery and photothermal therapy Discovered protease-dependent virulence factors critical for infection progression Funding Highlights: NIAID grants for sarA regulatory pathway studies Congressionally-Directed Medical Research Program grants for small molecule inhibitors Collaborative grants for nanotherapeutic and bone regeneration projects Dr. Smeltzer’s lab actively explores translational approaches to combat antibiotic-resistant infections, with a focus on clinical applications in orthopaedics and infectious diseases.

Ignacio Mir-Sanchisمشاهده پروفایل

استادیار

• Antimicrobial Resistance
• Phage Therapy
• Mobile Genetic Elements
• +۴ مورد دیگر

Ignacio Mir-Sanchis serves as Assistant Professor at Umeå University's Department of Medical Biochemistry and Biophysics and holds an affiliated position at the Wallenberg Centre for Molecular Medicine (WCMM). His research focuses on antimicrobial resistance mechanisms and phage therapy development. His primary research interests center on Mobile Genetic Elements (MGEs) in Staphylococcus aureus , particularly Methicillin-Resistant S. aureus (MRSA). His laboratory investigates how MGEs hijack host proteins for DNA replication and gene expression during horizontal transfer, identifying potential drug targets. Additional work explores bacteriophages as therapeutic tools against antibiotic-resistant infections, employing techniques from molecular biology to cryo-EM structural analysis. Recent publications reveal significant trends in bacterial defense mechanisms against viruses and protein dynamics related to antibiotic resistance spread. His 2025 discovery of bacterial viral defense systems provides new pathways for combating resistance. WCMM Fellow (2019) Swedish Research Council Grant (2023) As head of the Mir-Sanchis Lab, he leads research on antimicrobial resistance and phage therapy, with active projects in bacteriophage engineering for therapeutic applications and structural analysis of resistance mechanisms. Current work includes developing phage-like particles as biotechnology tools and investigating host protein hijacking by MGEs.

• Microbiology
• Infection Biology
• Immunology
• +۳ مورد دیگر

Prof. Friedrich Götz is a Senior Professor and Head of the Department of Microbial Genetics at the University of Tübingen, Germany. He has held this position since 2015, following his tenure as a full professor from 1987 to 2015. He is also a Visiting Professor at the Shiraz University of Medical Sciences (SUMS, 2020–present) and a member of the Cluster of Excellence - CMFI (2018–present). His academic journey includes a Ph.D. in Microbiology from Ludwig Maximilians University (LMU) Munich (1974–1978) and Habilitation at TU Munich (1985). His research focuses on microbial genetics, particularly the physiology of staphylococci, lipoprotein roles in immune responses, and bacterial-host interactions. Recent studies highlight microbiota-derived neurotransmitters influencing host cells and the development of novel antimicrobial compounds. His work has led to groundbreaking insights into skin microbiota's role in wound healing and neurochemical signaling. Prof. Götz has been awarded the DECHEMA Award (1989), DGHM Award (1991), and DGHM Lecturer Award (2009). He has served as President and Vice President of the VAAM (2003–2009), and has held leadership roles in major initiatives, including the DFG Graduate College 685 (2010–2011) and the Transregio SFB (2006–2013). He actively contributes to scientific publishing as an editor for journals like Molecular Microbiology and Medical Microbiology and Immunology, and advises international research institutions. His research spans over 380 peer-reviewed publications, with an h-index of 99, and has mentored over 120 PhD students and postdocs, many of whom have become professors. His lab, part of the Interfaculty Institute for Microbiology and Infection Medicine (IMIT), collaborates globally on microbial genetics and infection biology.

Mohamed Fakhrمشاهده پروفایل

استاد

• Molecular microbiology
• Foodborne bacterial pathogens
• Antimicrobial resistance
• +۷ مورد دیگر

Mohamed K. Fakhr, Ph.D., is a full-time Professor in the Department of Biological Sciences at The University of Tulsa, affiliated with the Oxley College of Health Sciences. His research focuses on molecular microbiology of foodborne pathogens, particularly Campylobacter and Staphylococcus aureus, examining antibiotic resistance mechanisms, plasmid characterization, and survival under extreme conditions. Ph.D., Oklahoma State University M.Sc., Zagazig University, Benha Branch B.Sc., Zagazig University, Benha Branch Research interests include: Molecular microbiology of foodborne pathogens Antimicrobial and heavy metal resistance Plasmid-mediated survival mechanisms Genomics and transcriptomics approaches Diversity of extremophilic actinomycetes Antimicrobial and antitumor metabolites His 2025 Google Scholar publications highlight advancements in Campylobacter aerotolerance, plasmid genomics, and extremophile metabolite discovery. Notable trends span food safety, bacterial stress response, and molecular typing methodologies. Scientific awards include: 2025 UTulsa Outstanding Teacher Award 2025 UTulsa Oxley College Teaching Excellence Award Dr. Fakhr's lab investigates polymicrobial interactions in retail meats, utilizes next-generation sequencing for plasmid analysis, and explores actinomycetes in extreme environments. His work bridges molecular biology and public health through pathogen characterization and teaching excellence.

• Medical Microbiology
• Antibiotic Resistance
• Bacteriophage Therapy
• +۲ مورد دیگر

Professor Mark Enright is a Professor of Medical Microbiology at Manchester Metropolitan University's Department of Life Sciences, specializing in genomic epidemiology of antibiotic-resistant pathogens and bacteriophage therapy development. His work bridges clinical microbiology with advanced genomic techniques to combat multidrug-resistant infections. His educational background includes: PhD in Medical Microbiology, University of Aberdeen (1995) MSc in Biochemistry, University of Dundee (1990) BSc (Hons) in Biological Sciences, University of Stirling (1989) Enright's research focuses on antibiotic resistance mechanisms in Gram-positive and Gram-negative pathogens, with groundbreaking work on bacteriophage-based therapeutics targeting Staphylococcus aureus , Pseudomonas aeruginosa , and Klebsiella pneumoniae . His laboratory employs whole-genome sequencing and core-genome MLST to track pathogen evolution, biofilm formation, and horizontal gene transfer. Recent projects include developing phage cocktails against cystic fibrosis-related infections and characterizing depolymerases for capsular polysaccharide degradation. Analysis of his 2015-2025 publications reveals consistent focus on genomic epidemiology of healthcare-associated pathogens, with increasing emphasis on phage therapy applications. His work demonstrates methodological evolution from traditional typing to advanced genomic analyses, particularly in tracking international MRSA transmission and developing phage-based biofilm disruption strategies for wound infections. His major recognitions include: Royal Society University Research Fellowship (2000-2008) European Society for Clinical Microbiology Young Investigator Award (2002) As Editor of the International Journal of Antimicrobial Agents and Section Editor for FEMS Microbiology Letters , Enright shapes antimicrobial research discourse. He serves on editorial boards of Antibiotics and PeerJ , and reviews for Science and Nature . His grant review expertise for Wellcome Trust, MRC, and EU programs informs global research funding priorities. Formerly a Visiting Professor at University of Bath (2011-2014), he maintains strong industry-academia collaborations in antimicrobial development. His Molecular Microbiology teaching integrates cutting-edge research into curriculum, while his John Dalton Building laboratory develops novel approaches to combat antimicrobial resistance through phage genomics and biofilm disruption technologies.

• Pediatric Infectious Diseases
• Antibiotic Resistance
• Vaccine Preventable Conditions
• +۷ مورد دیگر

Lilly Immergluck is a Professor in the Department of Pediatrics-Infectious Diseases at the University of Chicago. With over 25 years of experience, she specializes in pediatric infectious diseases, antibiotic resistance, and population health research focused on underserved communities, particularly addressing health disparities affecting children of color. Her work integrates geospatial statistical modeling to understand socio-environmental factors influencing infectious disease transmission. Education: B.A. in Biochemistry/Molecular and Cell Biology from Northwestern University (1986), M.D. from The Ohio State University College of Medicine (1990), M.S. in Clinical Research from Morehouse School of Medicine (2013). Training: Residency in Pediatrics (1993-1996) and Fellowship in Pediatric Infectious Diseases (1996) at the University of Chicago. Dr. Immergluck's research spans pediatric infectious diseases , antibiotic resistance , vaccine development , and public health . She has led clinical trials on SARS-CoV-2 vaccines through the U.S. COVID-19 Prevention Network and developed innovative models for geospatial analysis of health disparities. Her work addresses community-onset infections, vaccine hesitancy, and socio-ecological factors impacting childhood health. The trends in her publications reflect a focus on infectious disease epidemiology , clinical trials for vaccines , environmental health , and health equity . She has contributed significantly to understanding MRSA, rotavirus vaccines, and the impact of mask policies during pandemics. Scientific Awards: Pediatric Scientist Development Award (1994) Dr. Immergluck's grants include a five-year K08 award from the Agency for Healthcare Research and Quality (2015) for geospatial modeling of antibiotic resistance. She has held leadership roles at Morehouse School of Medicine (Director of Pediatric Clinical Translational Research Unit) and Emory University (Adjunct Associate Professor). Her career emphasizes mentoring future biomedical scientists and addressing systemic health inequities through research and clinical trial participation.

Laura Powerمشاهده پروفایل

دانشیار بالینی

• Public Health Practice
• Infectious Diseases
• Public Health Workforce Development
• +۳ مورد دیگر

Laura Power serves as Clinical Associate Professor in Epidemiology at the University of Michigan School of Public Health and Infectious Diseases (Internal Medicine), directing the Office of Public Health Practice. Her work bridges medical practice and public health through experiential learning, workforce development, and infectious disease epidemiology initiatives. Her educational background includes: BA from Albion College (1998) MD from Wayne State University School of Medicine (2002) MPH from University of Michigan School of Public Health (2015) Her research centers on public health practice systems, workforce capacity building, and infectious disease prevention. Recent projects include HRSA-funded Region V Public Health Training Center and Preventive Medicine Residency Program, focusing on applied epidemiology and outbreak response training. Her scholarly work demonstrates consistent emphasis on antimicrobial resistance, diagnostic accuracy, and translational public health practice. Her 15 most recent publications reveal strong focus on infectious disease epidemiology (73%), public health practice systems (60%), and antimicrobial resistance (47%), with growing emphasis on workforce development and outbreak response since 2016. Key trends include methodological innovation in surveillance systems and practical interventions for healthcare-associated infections. Dr. Power actively mentors students through the Public Health Action Support Team (PHAST) and Public Health in Action courses, connecting academic training with community practice. Her HRSA-funded programs support over 200 public health practitioners annually through the Region V Leadership Institute and residency training. She leads the Office of Public Health Practice, Region V Public Health Training Center, and Public Health Prepared program—fostering partnerships between academic, governmental, and community health organizations to enhance outbreak response capacity.

Carolyn Ibbersonمشاهده پروفایل

استادیار

• Microbiology
• Infectious Disease
• Microbial Ecology
• +۴ مورد دیگر

Carolyn Ibberson serves as an Assistant Professor of Microbiology at the University of Oklahoma, where she leads the Ibberson Lab focused on bacterial physiology in chronic human infections. Her research program addresses fundamental questions about how pathogens like Staphylococcus aureus establish and persist in chronic infections, with particular emphasis on polymicrobial interactions. B.S. in Biology from University of Wisconsin-Madison (2010) Ph.D. in Microbiology from University of Iowa (2015) Postdoctoral training at University of Texas at Austin (2015-2017) and Georgia Institute of Technology (2017-2021) Dr. Ibberson's research focuses on understanding bacterial physiology during human infection, particularly examining how co-infecting microbes influence S. aureus behavior and disease severity. Her work bridges classic microbiology with advanced genomic and computational approaches to address why chronic polymicrobial infections are notoriously difficult to treat, representing a significant healthcare burden costing over $20 billion annually in the United States. Her laboratory employs next-generation sequencing, microscopy, computational pipelines, and deep learning to investigate the molecular mechanisms of bacterial persistence and microbe-microbe interactions in chronic infection settings. Analysis of Dr. Ibberson's publications reveals a consistent focus on bacterial pathogenesis, particularly Staphylococcus aureus and Pseudomonas aeruginosa in human infections. Her work spans transcriptomics, biofilm formation, virulence factor regulation, and polymicrobial interactions, demonstrating an interdisciplinary approach that combines molecular microbiology with ecological and evolutionary perspectives. Her research trajectory shows increasing sophistication in methodologies, incorporating advanced genomic techniques and computational analysis to address complex questions in infection biology. Dr. Ibberson maintains an active research program through the Ibberson Lab at the University of Oklahoma, where she mentors students and collaborators in cutting-edge microbiological research. While specific grant information isn't detailed in the available materials, her publication record suggests successful funding for research on bacterial physiology in chronic infections, polymicrobial communities, and pathogen adaptation mechanisms. Her work has significant implications for developing new therapeutic approaches for difficult-to-treat chronic infections. The Ibberson Lab represents a dynamic research environment focused on understanding the fundamental biology of bacterial pathogens in clinically relevant contexts. The lab's work on spatial structure in microbial communities, host-pathogen interactions, and gene regulation during infection provides critical insights that could lead to novel antimicrobial strategies targeting the complex ecology of chronic infections.

• Microbial Ecology
• Biological Physics
• Biofilm Dynamics
• +۵ مورد دیگر

Dr William (Mack) Durham is a Senior Lecturer in Biological Physics at the University of Sheffield, affiliated with the School of Mathematical and Physical Sciences and the Department of Physics and Astronomy. His research focuses on microbial strategies for environmental exploitation, spanning biofilm dynamics, phytoplankton ecology, and porous environment microbiology. He holds a BSc from Clemson University and advanced degrees (SM/PhD) from MIT. Before joining Sheffield (2016-present), he was a Departmental Research Lecturer at the University of Oxford (2012-2016). Research interests include bacterial surface motility using pili, phytoplankton response to ocean turbulence, and competition in porous soils. His group employs microfluidics, molecular biology, and computational models. Current grants include BBSRC funding for chemotaxis studies and EPSRC support for interdisciplinary research. Awards include the HFSP Long-Term Fellowship and Andreas Acrivos Dissertation Award. Teaching responsibilities include undergraduate physics modules (e.g., PHY1001 Motion & Heat, PHY248 Labview) and advanced microscopy courses. He leads undergraduate admissions and coordinates degree programs with employment experience components. The Durham group comprises two postdocs (Jamie Wheeler and Oliver Meacock) and four PhD students. Labs/Teams: Imagine: Imaging Life Group, Biological Physics Research Group Key Projects: Bacterial spatial sensing, phytoplankton turbulence interaction, biofilm competition models

Cecilia M Thompsonمشاهده پروفایل

استادیار

• Molecular Diagnostics
• Clinical Microbiology
• Pediatric Infectious Diseases
• +۲ مورد دیگر

Cecilia M Thompson is an Assistant Professor in the Department of Pathology at Northwestern University Feinberg School of Medicine. She also serves as the Director of Clinical Microbiology at Ann & Robert H. Lurie Children's Hospital of Chicago, focusing on advanced molecular diagnostics and pediatric infectious diseases. BS: Loyola University Chicago (2012) MS: Loyola University Chicago (2014) PhD: Loyola University Chicago (2018) Postdoctoral Fellow: University of North Carolina Hospitals (2020) Her research centers on advanced molecular diagnostics , clinical microbiology education , and infectious diseases in immunocompromised and pediatric populations . Recent publications highlight antimicrobial therapy for MRSA bacteremia, bacterial pathogenesis, and SARS-CoV-2 symptom analysis. She maintains active professional society memberships including the Illinois Society for Microbiology, American Society for Microbiology, and Association for Molecular Pathology. Her work bridges clinical practice and academic research in pathogen detection and treatment strategies. Contact: cecilia.thompson@northwestern.edu | Location: 225 E Chicago Ave, Chicago, IL 60611